Melissa A Geller

9PUBLICATIONS
88CO-AUTHORS
Cancer geneticsTumour immunologyPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 22, 2026
Addressing sexual health after cancer: whose job is it anyway? Provider practices and communication barriers.

|Dec 21, 2025
TGF-βRII/IL-15 immunotherapeutic complex targets exhausted CD8+ T-cell subsets in lymph nodes and tumors.

Varghese K George, Hing C Wong, Martin Felices

|Nov 21, 2025
Assessment of Active Cytomegalovirus (CMV) and Epstein-Barr Virus (EBV) Infections and Patient Reported Fatigue in Ovarian Cancer Survivors.

Xuan Li, Katherine Brown, Kate Honeyfield

|Jun 26, 2025
HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers.

Nikitha Vobugari, Allison Makovec, Samuel Kellen

|Jun 09, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer.

Mary L Disis, Sarah F Adams, Jyoti Bajpai

|Feb 22, 2023
Reverse Translation Identifies the Synergistic Role of Immune Checkpoint Blockade and IL15 to Enhance Immunotherapy of Ovarian Cancer.

Martin Felices, Erin Wesley, Laura E Bendzick

Pageof 2

Frequent Collaborators

2 joint publications

Rachel I Vogel

2 joint publications

Martin Felices

2 joint publications

Emese Zsiros

2 joint publications

Kunle Odunsi